Press Releases Year None201920182017 May 16, 2019 Prevail Therapeutics Announces Executive Team Promotion and Appointments to Board of Directors March 27, 2019 Prevail Therapeutics Secures $50 Million in Series B Financing to Advance Pipeline of Gene Therapies for Neurodegenerative Diseases Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Displaying 11 - 12 of 12
